Difference between revisions of "Profiles"

From QIBA Wiki
Jump to: navigation, search
(Created page with "QIBA Profiles are published here when they complete one of the QIBA Profile Stages of development. ==Stage 3: Technically Confirmed== ==Stage 2: Publicly Reviewed==...")
 
 
(344 intermediate revisions by 7 users not shown)
Line 1: Line 1:
QIBA Profiles are published here when they complete one of the [[QIBA Profile Stages]] of development.
+
__NOTOC__
 +
Profiles published here have completed one of the '''[[QIBA Profile Stages]]''' of development and been approved by their [[Committees|Biomarker Committee]].
  
 +
Profiles '''[[How to use QIBA Profiles|may be of use]]''' at any Stage.
  
==Stage 3: Technically Confirmed==
+
===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed Profiles===
  
 +
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
 +
:* Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
 +
:* Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
  
==Stage 2: Publicly Reviewed==
+
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
 +
:* [[Media:UPICT Oncologic FDG-PETCTProtocol Dec-2014a.pdf|UPICT Protocol - Oncology FDG-PET CT v2.0 2014-12]]
  
 +
* [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-3.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]]
  
==Stage 1: Public Comment==
+
 
 +
===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles===
 +
 
 +
*[[Media:QIBA_CT_Lung_Density_Profile_090420-clean.pdf | QIBA CT Lung Density Profile_09.04.2020, clean version]] (Contains Conformance Checklist, Appendix B) 2020-10-23
 +
:*[[Media:QIBA CT Lung Density Protocols-Appendix E.xlsx|Appendix E:CT Lung Density Protocols 2019-06-26]]
 +
 
 +
*[[Media:QIBA_DSC-MRI_Stage2-Consensus_Profile.pdf| MR Dynamic Contrast Susceptibility (DSC) 2020-10-22]]
 +
 
 +
*[[Media:QIBA_DWIProfile_Consensus_Dec2019_Final.pdf| MR Diffusion-Weighted Imaging (DWI) 2019-12-20]]
 +
 
 +
*[[Media:QIBA_AmyloidPET_20June2018_consensus.pdf | PET F-18 for Amyloid 2018-06-20]]
 +
 
 +
*[[Media:MRE-QIBAProfile-2018-05-02-CONSENSUS.pdf | MR Elastography of the Liver 2018-05-02]]
 +
 
 +
*[[Media:001.QIBA_SPECT_Ioflupane Profile.v1.1 post-public comments.clean copy.2017 06 26.pdf | SPECT Ioflupane for Neurodegenerative Disease v1.1, 2017-06-26]]
 +
 
 +
*[[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane for Neurodegenerative Disease v2.0, 2019-10-15]]
 +
 
 +
:*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|Checklist - SPECT Profile Conformance]]
 +
 
 +
*[[Media:DCE-MRI Quantification Profile v1.0.pdf|MR DCE Quantification v1.0 2012-08-08]]
 +
 
 +
*[[Media:QIBA_CTA_Profile_as_of_2020-Mar-10.pdf| CTA Atherosclerosis 2020-03-10]]
 +
:*[[Media:QIBA_CTA_Field Test Checklist.xlsx| CTA Atherosclerosis Checklist 2020-05-28]]
 +
 
 +
*[[Media:QIBA_SPECT_99mTC_Profile_10.21.19.pdf|SPECT-CT: Estimating the Concentration of 99mTc Based Imaging Biomarkers in Large and Small Volumes of Interest Profile 2019-10-21]]
 +
 
 +
 
 +
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment Profiles===
 +
 
 +
'''Please submit comments using the '''[https://forms.gle/bPzUAuLKJnHYGbVS7 '''online form''']'''
 +
 
 +
*[[Media:QIBA_DCE-MRI_Profile-Stage_1-Public_Comment.pdf|MR DCE-MRI Quantification (DCEMRI-Q) 2020-10-12]] ('''closed''' on March 10, 2021)
 +
 
 +
*[[Media:QIBA_Profile_MSK-Cartilage-Stage1_Profile.pdf|MR MSK cartilage for joint disease 2020-05-18]] ('''closed''' on October 29, 2020)
 +
 
 +
*[[Media:QIBA_US_SWS_Profile_03.19.2021-clean version.pdf|US Shear Wave Speed for Liver Fibrosis 2021-03-19]] (clean version - Consensus vote)
 +
*[[Media:QIBA_US_SWS_Profile_03.19.2021-with edits.pdf|US Shear Wave Speed for Liver Fibrosis 2021-03-19]] (version with edits for Consensus vote)
 +
 
 +
:*[[Media:SWS Checklists-Appendix E-03.19.2021.xlsx|Appendix E: SWS Checklists]] (updated March 19, 2021)
 +
 
 +
*[[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| fMRI for Sensorimotor Mapping 2017-06-19]] ('''closed''' on December 31, 2017)
 +
 
 +
 
 +
'''[[Comment Resolutions]]''' <font color=black>are posted for '''Past Public Comments''' and '''Past Technical Confirmations'''.<font>
 +
 
 +
 
 +
====Format for Citing Profiles====
 +
Cite QIBA Profile documents as:
 +
 
 +
: ''Specific QIBA Biomarker Committee. Specific Profile Title'', Quantitative Imaging Biomarkers Alliance. ''Version. Profile Stage''. ''Date''. Available from: ''URL''
 +
 
 +
Example:
 +
 
 +
: QIBA MR Biomarker Committee. MR Elastography of the Liver, Quantitative Imaging Biomarkers Alliance. Profile Stage: Consensus. June 6, 2019. Available from: http://qibawiki.rsna.org/index.php/Profiles
 +
 
 +
 
 +
====Statements of Endorsement====
 +
*[[Industry]]
 +
*[[Clinical Sites]]
 +
*[[Additional letters of support can be found here]]
 +
 
 +
 
 +
====See Also====
 +
*[[How to use QIBA Profiles]]
 +
*[[Committees|Biomarker Committee]] pages may also have links to DRAFT Profile documents for the next Stage.
 +
*[[Profile Conformance]] describes how sites and products claim conformance to a Profile.
 +
*[[QIBA Profile Template]] shows the structure, rationale and content of a Profile (''show "All Markup" to see guidance in the Word comments'')
 +
 
 +
*[[Work Product for Review]]

Latest revision as of 16:28, 6 April 2021

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Profiles may be of use at any Stage.

Stage 3: Technically Confirmed Profiles

  • Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
  • Assessment Procedures (refer to Section 4 in the Profile document - pg 30)


Stage 2: Consensus Profiles


Stage 1: Public Comment Profiles

Please submit comments using the online form


Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations.


Format for Citing Profiles

Cite QIBA Profile documents as:

Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. Date. Available from: URL

Example:

QIBA MR Biomarker Committee. MR Elastography of the Liver, Quantitative Imaging Biomarkers Alliance. Profile Stage: Consensus. June 6, 2019. Available from: http://qibawiki.rsna.org/index.php/Profiles


Statements of Endorsement


See Also